Position in LLY
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$1,531,865,340
+$456,629,382 QoQ
Shares Held
1,277,161
+9.2% QoQ
Ownership
0.136%
of shares outstanding
% of Portfolio
1.15%
of 13F equity value
Holder Rank
#64
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026SCHRODER INVESTMENT MANAGEMENT GROUP holds $4,791,103,609 across 11 Drug Manufacturers - General names. LLY ranks #1 (32.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
1,277,161 | $1,531,865,340 | |
| 2 | JNJ |
Johnson & Johnson
|
3,563,268 | $904,963,170 | |
| 3 | BMY |
Bristol Myers Squibb Co
|
12,226,954 | $704,517,086 | |
| 4 | ABBV |
AbbVie Inc.
|
2,280,159 | $573,779,209 | |
| 5 | MRK |
Merck & Co., Inc.
|
2,455,664 | $315,552,823 | |
| 6 | PFE |
Pfizer Inc
|
12,896,296 | $310,542,805 | |
| 7 | AMGN |
Amgen Inc
|
613,694 | $222,230,868 | |
| 8 | GILD |
Gilead Sciences, Inc.
|
1,705,761 | $215,505,842 |
All Filings in LLY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,531,865,340 | 1,277,161 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,075,235,958 | 1,169,027 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $2,093,152,275 | 1,947,698 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $1,423,358,188 | 1,865,476 | Shares | Sole | 2025-11-13 | |
| 2025-06-30 | $1,491,597,909 | 1,913,458 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $1,434,053,131 | 1,736,331 | Shares | Sole | 2025-05-13 | |
| 2024-12-31 | $1,302,041,304 | 1,686,582 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $1,489,453,840 | 1,681,213 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $1,660,420,739 | 1,833,949 | Shares | Sole | 2024-08-12 | |
| 2024-03-31 | $1,647,690,492 | 2,117,963 | Shares | Sole | 2024-05-14 | |
| 2023-12-31 | $1,273,527,470 | 2,184,738 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $1,235,415,646 | 2,300,031 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $1,128,136,544 | 2,405,511 | Shares | Sole | 2023-08-11 | |
| 2023-03-31 | $795,913,276 | 2,317,609 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $833,649,114 | 2,278,726 | Shares | Sole | 2023-02-10 | |
| 2022-09-30 | $769,330,482 | 2,379,250 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $605,366,586 | 1,867,090 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $571,504,308 | 1,995,685 | Shares | Sole | 2022-05-16 | |
| 2021-12-31 | $547,911,093 | 1,983,604 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $389,306,539 | 1,684,945 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $449,009,282 | 1,956,297 | Shares | Sole | 2021-08-13 | |
| 2021-03-31 | $340,829,732 | 1,824,375 | Shares | Sole | 2021-05-28 | |
| 2020-12-31 | $370,439,515 | 2,194,027 | Shares | Sole | 2021-02-16 | |
| 2020-09-30 | $281,686,051 | 1,903,027 | Shares | Sole | 2020-11-13 | |
| 2020-06-30 | $278,801,772 | 1,698,147 | Shares | Sole | 2020-08-13 | |
| 2020-03-31 | $260,132,735 | 1,875,236 | Shares | Sole | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||